171 related articles for article (PubMed ID: 38264612)
1. Therapeutic effects of a novel venom abstract (ZK002) solution in an alkali-burned corneal wound-healing model.
Peng WY; Wang F; Yang SJ; Sun QY; Zhou HS; Li X; Jiang ZX; Zhou SY
Mol Vis; 2023; 29():317-328. PubMed ID: 38264612
[TBL] [Abstract][Full Text] [Related]
2. An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model.
Uchiyama M; Shimizu A; Masuda Y; Nagasaka S; Fukuda Y; Takahashi H
Mol Vis; 2013; 19():2135-50. PubMed ID: 24194635
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of zerumbone in an alkali-burned corneal wound healing model.
Kim JW; Jeong H; Yang MS; Lim CW; Kim B
Int Immunopharmacol; 2017 Jul; 48():126-134. PubMed ID: 28501766
[TBL] [Abstract][Full Text] [Related]
4. Characterization of C-X-C chemokine receptor type 5 in the cornea and role in the inflammatory response after corneal injury.
Balne PK; Gupta S; Landon KM; Sinha NR; Hofmann AC; Hauser N; Sinha PR; Huang H; Kempuraj D; Mohan RR
Exp Eye Res; 2023 Jan; 226():109312. PubMed ID: 36400287
[TBL] [Abstract][Full Text] [Related]
5. Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model.
Nakano Y; Arima T; Tobita Y; Uchiyama M; Shimizu A; Takahashi H
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707656
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor alpha agonist suppresses neovascularization by reducing both vascular endothelial growth factor and angiopoietin-2 in corneal alkali burn.
Arima T; Uchiyama M; Nakano Y; Nagasaka S; Kang D; Shimizu A; Takahashi H
Sci Rep; 2017 Dec; 7(1):17763. PubMed ID: 29259285
[TBL] [Abstract][Full Text] [Related]
7. Forkhead Domain Inhibitor-6 Suppresses Corneal Neovascularization and Subsequent Fibrosis After Alkali Burn in Rats.
Lan C; Liu G; Huang L; Wang X; Tan J; Wang Y; Fan N; Zhu Y; Yu M; Liu X
Invest Ophthalmol Vis Sci; 2022 Apr; 63(4):14. PubMed ID: 35446346
[TBL] [Abstract][Full Text] [Related]
8. The role of pirfenidone in alkali burn rat cornea.
Jiang N; Ma M; Li Y; Su T; Zhou XZ; Ye L; Yuan Q; Zhu P; Min Y; Shi W; Xu X; Lv J; Shao Y
Int Immunopharmacol; 2018 Nov; 64():78-85. PubMed ID: 30153530
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of clinical and histological effects of KGF-2 and NGF on corneal wound healing in an experimental alkali burn rabbit model.
Ergen SK; Subasi S; Rencber SF; Duruksu G; Yazir Y
Exp Eye Res; 2022 Oct; 223():109190. PubMed ID: 35963307
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin inhibits corneal inflammatory response and neovascularization in a mouse model of corneal alkali burn.
Li J; Han J; Shi Y; Liu M
Exp Eye Res; 2023 Aug; 233():109539. PubMed ID: 37315833
[TBL] [Abstract][Full Text] [Related]
11. Effects of nicotine on corneal wound healing following acute alkali burn.
Kim JW; Lim CW; Kim B
PLoS One; 2017; 12(6):e0179982. PubMed ID: 28644870
[TBL] [Abstract][Full Text] [Related]
12. Allograft survival enhancement using doxycycline in alkali-burned mouse corneas.
Ling S; Li W; Liu L; Zhou H; Wang T; Ye H; Liang L; Yuan J
Acta Ophthalmol; 2013 Aug; 91(5):e369-78. PubMed ID: 23387987
[TBL] [Abstract][Full Text] [Related]
13. Expression of collagen I, smooth muscle alpha-actin, and vimentin during the healing of alkali-burned and lacerated corneas.
Ishizaki M; Zhu G; Haseba T; Shafer SS; Kao WW
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3320-8. PubMed ID: 8225867
[TBL] [Abstract][Full Text] [Related]
14. AIP1 suppresses neovascularization by inhibiting the NOX4-induced NLRP3/NLRP6 imbalance in a murine corneal alkali burn model.
Li Q; Hua X; Li L; Zhou X; Tian Y; Deng Y; Zhang M; Yuan X; Chi W
Cell Commun Signal; 2022 May; 20(1):59. PubMed ID: 35524333
[TBL] [Abstract][Full Text] [Related]
15. Upadacitinib inhibits corneal inflammation and neovascularization by suppressing M1 macrophage infiltration in the corneal alkali burn model.
Yu J; Shen Y; Luo J; Jin J; Li P; Feng P; Guan H
Int Immunopharmacol; 2023 Mar; 116():109680. PubMed ID: 36739832
[TBL] [Abstract][Full Text] [Related]
16.
Estrella-Mendoza MF; Jiménez-Gómez F; López-Ornelas A; Pérez-Gutiérrez RM; Flores-Estrada J
Nutrients; 2019 May; 11(5):. PubMed ID: 31137826
[TBL] [Abstract][Full Text] [Related]
17. Minocycline inhibits alkali burn-induced corneal neovascularization in mice.
Xiao O; Xie ZL; Lin BW; Yin XF; Pi RB; Zhou SY
PLoS One; 2012; 7(7):e41858. PubMed ID: 22848638
[TBL] [Abstract][Full Text] [Related]
18. The wound healing effects of vitamin A eye drops after a corneal alkali burn in rats.
Kim EC; Kim TK; Park SH; Kim MS
Acta Ophthalmol; 2012 Nov; 90(7):e540-6. PubMed ID: 23106861
[TBL] [Abstract][Full Text] [Related]
19. Effect of overexpression of PPARgamma on the healing process of corneal alkali burn in mice.
Saika S; Yamanaka O; Okada Y; Miyamoto T; Kitano A; Flanders KC; Ohnishi Y; Nakajima Y; Kao WW; Ikeda K
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C75-86. PubMed ID: 17625041
[TBL] [Abstract][Full Text] [Related]
20. Doxycycline enhances the inhibitory effects of bevacizumab on corneal neovascularization and prevents its side effects.
Su W; Li Z; Li Y; Lin M; Yao L; Liu Y; He Z; Wu C; Liang D
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9108-15. PubMed ID: 22039247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
